Cytosorbents

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO

Phillip P. Chan

CEOPhillip P. Chan

Employees

149

Employees149

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1997

Founded1997

Employees

149

Employees149

CTSO Key Statistics

Market cap

52.58M

Market cap52.58M

Price-Earnings ratio

-4.50

Price-Earnings ratio-4.50

Dividend yield

—

Dividend yield—

Average volume

58.98K

Average volume58.98K

High today

$0.86

High today$0.86

Low today

$0.816

Low today$0.816

Open price

$0.83

Open price$0.83

Volume

18.83K

Volume18.83K

52 Week high

$1.61

52 Week high$1.61

52 Week low

$0.7101

52 Week low$0.7101

CTSO News

TipRanks 23h

CytoSorbents’ STAR Registry: A Closer Look at the Latest Clinical Study Update

Cytosorbents Corp ((CTSO)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off...

People also own

Based on the portfolios of people who own CTSO. This list is generated using Robinhood data, and it’s not a recommendation.